133 - 144 of 7633 results

COVID-19 Disease State Podcast Series

Industry Podcast Series Sponsored by GlaxoSmithKline; Not for CME/CE Credit


words spelling copd

Learn about the role of dual and triple therapy and evidence-based treatment selection for the individualized management of COPD, as well as strategies for assessing patients with undiagnosed COPD and preventing exacerbations in patients with COPD, by completing all the activities in this curriculum, designed specifically for clinicians practicing in a primary care setting.


The Continuum of Heart Failure

Industry Podcast Series Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC. Not for CME/CE Credit

• Chapter 1 | The Continuum of Heart Failure: Classifying Heart Failure Listen to 2 key experts as they review the types, classification, and pathophysiology of heart failure. • Chapter 2 | The Continuum of Heart Failure: The Interconnected Nature of the Cardio-Renal-Metabolic (CRM) Systems The cardiovascular, renal, and metabolic systems are interconnected. Listen as Melissa Magwire, RN,MSN,CDE and James O’Keefe, MD discuss how these three systems impact each other, and the effect that these connections have on patients with heart failure. • Chapter 3 | The Continuum of Heart Failure: Heart Failure and Type 2 Diabetes: Assessment of Patient Care Listen as Melissa Magwire, RN,MSN,CDE and James O’Keefe, MD explore the link between heart failure and diabetes through a patient case. This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.


Physician attending to patient

Maximum 50 words to introduce the activity The percentage of individuals with T2D achieving A1C <7% worsened from 2015-2018. Therapeutic inertia—failure to initiate or intensify treatment in a timely manner—is largely responsible for this problem. This program will support PCPs in overcoming therapeutic inertia through timely initiation and advancement of treatment with GLP-1 RAs and review guideline updates that support use of GLP-1 RA early in the treatment paradigm.


woman holding her stomach speaking with a doctor

Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people and 40% suffers remain undiagnosed.


FAQ for HIV for the Clinician in Practice

Guest: Stephen Symes, MD, FACP


0.25 CME CREDIT

Through fifteen quick-hitting cases, this session will review select dermatologic rashes and neoplasms, both benign and malignant, that are commonly encountered by primary care physicians. Clinical descriptions of acne, alopecia areata, atopic dermatitis/eczema, lichen planus, pityriasis rosea, psoriasis, rosacea, seborrheic dermatitis, stasis dermatitis, tinea cruris/corporis/unguium, acrochordon, cherry angioma, seborrheic keratosis, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, and melanoma are provided, followed by suggestions for treatment and management within the scope of primary care. Recommendations as to when to refer patients to Dermatology are noted. Reference atlas, textbook, website, and mobile application recommendations are also provided.


FAQ for HIV Update for the Non-ID Specialist: What Every Clinician Needs to Know

This case-based, interactive lecture will cover the current epidemiology of HIV in the United States, and then focus on issues critical for the primary care provider - HIV testing, identification of acute infection, initiating a baseline work-up, and understanding the basics of antiretroviral therapy. HIV prevention will be covered citing both the pre- and post-exposure prophylaxis strategies.Guest: Paul E. Sax, MD

This case-based, interactive lecture will cover the current epidemiology of HIV in the United States, and then focus on issues critical for the primary care provider - HIV testing, identification of acute infection, initiating a baseline work-up, and understanding the basics of antiretroviral therapy. HIV prevention will be covered citing both the pre- and post-exposure prophylaxis strategies.


Keeping up with the many new drugs approved for use in the U.S. each year is a constant challenge. However, only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk will provide a balanced evaluation of these important novel drugs and address efficacy, side effects, cost, and the impact on primary care practice.